Form 8-K GLOBUS MEDICAL INC For: Aug 04
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Wall St futures pause after AI rally, focus on Mideast tensions
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Globus Medical (GMED) PT Raised to $100 at Northland Capital Markets
August 5, 2021 7:36 AM EDTNorthland Capital Markets analyst Jason Wittes raised the price target on Globus Medical (NYSE: GMED) to $100.00 while maintaining an Outperform rating.
The analyst commented, "GMED reported record revenues in 2Q21 of $251.0 million, up 68.6% y/y (up 67.9% cc y/y), easily beating consensus of... More
Globus Medical (GMED) PT Raised to $89 at Truist Securities
August 5, 2021 6:29 AM EDTTruist Securities analyst Samuel Brodovsky raised the price target on Globus Medical (NYSE: GMED) to $89.00 (from $82.00) while maintaining a Buy rating.
The analyst commented, "GMED announced 2Q results that saw revenue comfortably beat the Street. Guidance was raised on both... More
